{"id":"https://openalex.org/W3208944682","doi":"https://doi.org/10.53879/id.54.10.11138","title":"STABILITY INDICATING LIQUID CHROMATOGRAPHIC ASSESSMENT OF DOLUTEGRAVIR BY AQBD APPROACH \u2013 CENTRAL COMPOSITE DESIGN","display_name":"STABILITY INDICATING LIQUID CHROMATOGRAPHIC ASSESSMENT OF DOLUTEGRAVIR BY AQBD APPROACH \u2013 CENTRAL COMPOSITE DESIGN","publication_year":2017,"publication_date":"2017-10-28","ids":{"openalex":"https://openalex.org/W3208944682","doi":"https://doi.org/10.53879/id.54.10.11138","mag":"3208944682"},"language":"en","primary_location":{"id":"doi:10.53879/id.54.10.11138","doi":"https://doi.org/10.53879/id.54.10.11138","is_oa":false,"landing_page_url":"https://doi.org/10.53879/id.54.10.11138","pdf_url":null,"source":{"id":"https://openalex.org/S2764981170","display_name":"INDIAN DRUGS","issn_l":"0019-462X","issn":["0019-462X","3048-7161"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4353105718","host_organization_name":"Indian Drug Manufacturers' Association (IDMA)","host_organization_lineage":["https://openalex.org/P4353105718"],"host_organization_lineage_names":["Indian Drug Manufacturers' Association (IDMA)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"INDIAN DRUGS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110637875","display_name":"Sunitha G N","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Sunitha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023435426","display_name":"Panikumar Durga Anumolu","orcid":"https://orcid.org/0000-0001-5010-7488","observed_orcids":["https://orcid.org/0000-0001-5010-7488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. D Anumolu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002080918","display_name":"C.V.S. Subrahmanyam","orcid":"https://orcid.org/0000-0002-5645-1922","observed_orcids":["https://orcid.org/0000-0002-5645-1922"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C.V.S Subrahmanyam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062994939","display_name":"G. Mounika","orcid":"https://orcid.org/0000-0001-5077-1426","observed_orcids":["https://orcid.org/0000-0001-5077-1426"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G Mounika","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5056145086","display_name":"B. Priyanka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Priyanka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5835,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.5696013,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"54","issue":"10","first_page":"44","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10908","display_name":"Analytical Chemistry and Chromatography","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dolutegravir","display_name":"dolutegravir","score":0.9990000128746033},{"id":"https://openalex.org/keywords/analytical-quality-by-design","display_name":"analytical quality by design","score":0.8679999709129333},{"id":"https://openalex.org/keywords/central-composite-design","display_name":"central composite design","score":0.7739999890327454},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.8730000257492065},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.5860000252723694},{"id":"https://openalex.org/keywords/degradation-products","display_name":"degradation products","score":0.6909999847412109},{"id":"https://openalex.org/keywords/degradation-pathways","display_name":"degradation pathways","score":0.9240000247955322},{"id":"https://openalex.org/keywords/stability-indicating-method","display_name":"stability-indicating assay","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.8304005265235901},{"id":"https://openalex.org/C2775986502","wikidata":"https://www.wikidata.org/wiki/Q420466","display_name":"Ammonium formate","level":3,"score":0.6407490968704224},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.6179074048995972},{"id":"https://openalex.org/C172120300","wikidata":"https://www.wikidata.org/wiki/Q1134348","display_name":"Volumetric flow rate","level":2,"score":0.5783344507217407},{"id":"https://openalex.org/C169222746","wikidata":"https://www.wikidata.org/wiki/Q4116558","display_name":"Factorial experiment","level":2,"score":0.5652101635932922},{"id":"https://openalex.org/C92397422","wikidata":"https://www.wikidata.org/wiki/Q5062082","display_name":"Central composite design","level":3,"score":0.5547797679901123},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5037724375724792},{"id":"https://openalex.org/C2777463227","wikidata":"https://www.wikidata.org/wiki/Q408047","display_name":"Acetonitrile","level":2,"score":0.49023038148880005},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.4689920246601105},{"id":"https://openalex.org/C9893847","wikidata":"https://www.wikidata.org/wiki/Q1425625","display_name":"Reproducibility","level":2,"score":0.46364131569862366},{"id":"https://openalex.org/C3020018676","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Retention time","level":2,"score":0.4448777735233307},{"id":"https://openalex.org/C2780782300","wikidata":"https://www.wikidata.org/wiki/Q410156","display_name":"Ammonium acetate","level":3,"score":0.43658262491226196},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.4056823253631592},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.394949346780777},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.24868080019950867},{"id":"https://openalex.org/C150077022","wikidata":"https://www.wikidata.org/wiki/Q3136137","display_name":"Response surface methodology","level":2,"score":0.15077415108680725},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.11464390158653259},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53879/id.54.10.11138","doi":"https://doi.org/10.53879/id.54.10.11138","is_oa":false,"landing_page_url":"https://doi.org/10.53879/id.54.10.11138","pdf_url":null,"source":{"id":"https://openalex.org/S2764981170","display_name":"INDIAN DRUGS","issn_l":"0019-462X","issn":["0019-462X","3048-7161"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4353105718","host_organization_name":"Indian Drug Manufacturers' Association (IDMA)","host_organization_lineage":["https://openalex.org/P4353105718"],"host_organization_lineage_names":["Indian Drug Manufacturers' Association (IDMA)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"INDIAN DRUGS","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.4043000042438507,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1866341078","https://openalex.org/W2053884177","https://openalex.org/W2115580633","https://openalex.org/W2209196016","https://openalex.org/W2217058597","https://openalex.org/W2316546164","https://openalex.org/W2319787546","https://openalex.org/W2369824948","https://openalex.org/W2406931452","https://openalex.org/W2470431263","https://openalex.org/W2504115930","https://openalex.org/W2598207006","https://openalex.org/W2800479026","https://openalex.org/W4253540297","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W7222812761","https://openalex.org/W7084037293","https://openalex.org/W6930810976","https://openalex.org/W7167355126","https://openalex.org/W7162878604","https://openalex.org/W7118236397","https://openalex.org/W4414449595","https://openalex.org/W4387785118","https://openalex.org/W7162627681","https://openalex.org/W3211147357"],"abstract_inverted_index":{"Based":[0],"on":[1,96],"the":[2,54,120,187],"current":[3],"regulatory":[4],"requirements":[5],"for":[6,13,148,175],"analytical":[7,25,64],"method":[8,12,65,163,172],"development,":[9],"a":[10,86],"RP-HPLC":[11],"quality":[14,26],"control":[15],"of":[16,56,76,89,107,122,139,177,191,196],"dolutegravir":[17,197],"in":[18,40,92,119,189],"dosage":[19,179],"form":[20,180],"has":[21],"been":[22],"optimized":[23,68],"using":[24],"by":[27,35,202],"design":[28,39],"(AQbD)":[29],"approach.":[30],"Experimental":[31],"observations":[32],"were":[33,67,198],"analysed":[34],"full":[36],"factorial":[37],"experimental":[38,160],"Sigmatech":[41],"software":[42],"with":[43,104,125,158],"two":[44],"variables":[45],"(flow":[46],"rate":[47,88],"and":[48,78,127,133,154,182,200,204],"%":[49,73],"organic":[50],"mobile":[51,70],"phase)":[52],"whilst":[53],"number":[55],"theoretical":[57,149],"plates":[58,150],"was":[59,117,151,156,164,173],"considered":[60],"as":[61,69,166],"response.":[62],"The":[63,110,142,162,170],"conditions":[66],"phase":[71],"(40:60":[72],"V/V)":[74],"consisting":[75],"acetonitrile":[77],"ammonium":[79],"formate":[80],"buffer,":[81],"pH":[82],"3.0":[83],"pumped":[84],"at":[85,131,136],"flow":[87],"0.6":[90],"mL/min":[91],"an":[93],"isocratic":[94],"mode":[95],"SPOLAR":[97],"C18":[98],"Column":[99],"(250":[100],"x":[101],"4.6mm,":[102],"5\u03bcm)":[103],"run":[105],"time":[106,138],"15":[108],"min.":[109,141],"plot":[111],"between":[112],"peak":[113],"area":[114],"vs.":[115],"concentration":[116],"rectilinear":[118],"range":[121],"5-30":[123],"\u03bcg/mL":[124],"detection":[126],"quantification":[128],"limit":[129],"values":[130],"0.01":[132],"0.3\u03bcg/mL,":[134],"respectively":[135],"retention":[137],"13":[140],"predicted":[143],"data":[144],"from":[145],"contour":[146],"diagram":[147],"verified":[152],"virtually":[153],"it":[155],"contented":[157],"concrete":[159],"data.":[161,207],"validated":[165],"per":[167],"ICH":[168],"guidelines.":[169],"proposed":[171],"pertinent":[174],"assay":[176],"marketed":[178],"(Tivicay)":[181],"further":[183],"extended":[184],"to":[185],"quantify":[186],"drug":[188],"prevalence":[190],"degradation":[192],"products.":[193],"Degradation":[194],"pathways":[195],"postulated":[199],"characterized":[201],"IR":[203],"mass":[205],"spectral":[206]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2021-11-08T00:00:00"}